Dr. Sophie Olivier is responsible for clinical development. A physician by background, she has extensive clinical development experience in large and small pharma organizations and has overseen multiple regulatory interactions with both the FDA and the EMA, particularly in regard to pediatric regulation. Prior to joining Lysogene, Dr. Oliver was Chief Medical Officer at Genticel. Before joining Genticel, she worked as Scientific Officer, Pediatric Team, at the European Medicines Agency in London. Previously, Dr. Olivier led clinical development in Women’s Health diseases at Wyeth Pharmaceutical (Philadelphia Area, US). With her extensive career as a senior manager in the industry, spanning from early development to ensuring market access, Dr. Olivier brings a rich breadth of experience across a variety of therapeutic areas to Lysogene.